|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 94.19 EGP | 0.00% |
|
0.00% | +35.27% |
The Arab Drug Company reported earnings results for the first quarter ended September 30, 2022. For the first quarter, the company reported revenue was EGP 153.94 million compared to EGP 144.07 million a year ago. Net income was EGP 27.7 million compared to EGP 25.69 million a year ago.
Basic earnings per share from continuing operations was EGP 3.98 compared to EGP 3.82 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +35.27% | 11.8M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
THE ARAB DRUG COMPANY 
